Introduction
Human immunodeficiency virus type 1 (HIV-1) is a pathogenic retrovirus responsible for AIDS in humans. After primary infection, viraemia is followed by specific antibody production and disappearance of circulating virus. The subsequent progression to frank disease is characterized by increasing numbers of infected cells, reappearance of circulating virus, progressive impairment of the immune system and the onset of opportunistic infections (Simmonds et al., 1990; Brinchmann et al., 1991) . The asymptomatic period between primary infection and the subsequent progression to disease can vary from a few months to several years (Friedland et al., 1991; Hardy et al., 1991) .
Several hypotheses have been proposed to explain the maintenance of the latent phase (Walker et al., 1987 (Walker et al., , 1988 Blumberg et al., 1987; Rook et al., 1987; Kannagi et al., 1990) . In vitro evidence indicates that different exogenous stimuli such as cytokines (Duh et al., 1989; Matsuyama et al., 1989; Poli et al., 1990) , viruses (Mosca et al., 1987) and mitogens and chemical treatment (Folks et al., 1986; Siekevitz et al., 1987; Zack et al., 1988; Valerie et al., 1988 ) may facilitate and/or reactivate the transcription of latent HIV-1.
Although HIV-1 was originally characterized as a cytopathic T cell-lymphotropic virus causing infection and depletion of CD4 ÷ cells, its host range has since been shown to be less restricted (Feny6 et al., 1989; Von Briesen et al., 1990) .
HIV-infected cells accommodate more than a single virus variant so that replication-competent and -defective proviruses may coexist within a single infected cell (Fisher et al., 1988; Wain-Hobson, 1989; Balachandran et al., 1991) , possibly representing a virus reservoir. The ability of defective viral genomes to generate infectioncompetent virus through complementation or recombination may play an important role in AIDS pathogenesis (Clavel et al., 1989; Inoue et al., 1991) .
Increasing amounts of data indicate that integrated and unintegrated forms of viral DNA are present in tissue samples of HIV-1 seropositive subjects. High levels of unintegrated forms of HIV-1 DNA were found in fresh tissues derived from patients with AIDS-related complex or AIDS (Shaw et al., 1984) and in the brain of AIDS dementia cases (Pang et al., 1990) . Similar
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patterns have been found in tissues of simian immunodeficiency virus-infected monkeys during the last phase of the disease (Hirsch et al., 1990) and also during in vivo infections by feline leukaemia and equine infectious anaemia viruses (Mullins et al., 1986; Rasty et al., 1990) .
Although it has been observed in vitro that accumulation of unintegrated viral DNA and high level RNA expression are correlated with a cytocidal effect (Somasundaran & Robinson, 1988) , the role of unintegrated and integrated viral forms in the establishment of a persistent infection or in the progression to disease in humans remains to be elucidated. Further, very little information is available regarding the status of the HIV genome in asymptomatic subjects, particularly in those who remain asymptomatic for a number of years.
It is well known that the survival of primary cultures of both HIV-infected and uninfected human peripheral blood lymphocytes (PBLs) in vitro may be 30 to 40 days, although it is shorter in HIV-infected PBLs. In this study, cultures of PBLs from an HIV-1 seropositive, asymptomatic homosexual patient exhibited a much longer survival curve and did not release extracellular virus, even after cocultivation with HUT-78 ceils. Upon cloning by limiting dilution, two cell lines (FT1 and FT4) were established in vitro; these showed autonomous growth and a very immature T cell phenotype. Extrachromosomal forms of HIV-1 viral DNA but not integrated provirus were detected in both cell lines as well as in the original sample of uncultured PBLs from the same subject. Furthermore, both cell lines (negative for CD4 membrane receptor) are susceptible to CD4-independent HIV-1 superinfection.
Methods
Cell lines and PBL cloning. H9, H9/HTLV-IIIB (kindly provided by Dr R. C. Gallo, Bethesda, Md., U.S.A.), 8E5 (from Dr T_ Folks in the framework of the AIDS Research Reference Reagent Program, Division of AIDS, NIAID, NIH, U.S.A.), HUT-78, C8166 and CEMss cell lines were maintained in RPMI 1640 medium (Flow Laboratories) supplemented with 15% foetal calf serum (FCS), penicillin (100 units/ml) and streptomycin (100 ~tg/ml). Cell lines were split biweekly and maintained at 37 °C in 5% CO2. Ficoll-separated lymphocytes from peripheral blood were stimulated for 48 h with phytohaemagglutinin (PHA) and cultured in RPMI 1640 medium containing 20% heat-inactivated FCS, 10% PHA-free human leukocyte conditioned medium, used as a source of interleukin-2 (IL-2; Janssen) as described elsewhere (Rossi et al., 1988) . PBLs were then cloned by limiting dilution in 96-weU flat microtitre plates in the presence of 10% IL-2 without a feeder layer; and incubated at 37 °C in 5% C02.
Bacto-agar cloning and tumorigenicity study. FT1 and FT4 cells during the log phase of growth were cloned in 0.3% bacto-agar (Flow Laboratories) with and without IL-2. On day 10, colonies were counted under an inverted microscope (Labovert; Leitz). To test for tumorigenicity, 2 x 107 cells resuspended in pyrogen-free saline solution (NaC1) were injected subcutaneously into CD1 nude mice (Charles River Laboratories). Mice were examined weekly for 2 months for tumour growth.
Cytokine detection in cell-free supernatant. IL-2, IL-4, IL-6, tumour necrosis factor ct (TNF-~t) and granular macrophage colony-stimulating factor (GM-CSF) were measured using ELISA (R&D System). The cell supernatants were also titrated for interferon (IFN) activity by a microtitre assay based on the inhibition of c.p.e, using WISH cells and Sindbis virus as described (Stanton et al., 1981) . To identify the IFN type, anti-IFN<t, -/~ and -~ polyclonal sera were used in the same test.
Analysis of cytoplasmic enzymes and cell surface antigens by using monoclonal antibodies (MAbs) . Cell phenotype characterization was carried out by indirect immunofluorescence. Cells (106) were incubated in 100 ~tl of Iscove's medium with the appropriate concentration of MAbs (OKT3, OKT4, OKT6, OKT8, OKT9 and OKT16, Ortho Diagnostic; anti-HLA-A, -B, -C, anti-HLA-DP, -DQ and -DR, Leu7, Leull, Leul9, Leul2, Leul4, Leul6, TCRct//~, HPCA-I, Becton Dickinson; anti-a-chain IL-2R, human IgG, IgA, IgM and IgD, Technogenetics, who kindly provided the anti-~-chain [L-2R MAb TU-207). After 60 min in ice, samples were washed twice in PBS and incubated for 60 min in ice with 100 ~tl of the suggested dilution of a 1:40 goat fluorescein isothiocyanate-labelled anti-mouse IgG. Thereafter, the samples were washed twice, fixed with 3% formalin and analysed by cytofluorometry (FACscan; Becton Dickinson). For analysis of cytoplasmic enzymes, cytocentrifuge preparations were airdried, fixed with cold acetone for 5 rain and either stained with May Grunwald-Giemsa stain for cytoplasmic proteins, or tested for the cytoplasmic enzymes acid ~-naphthyl acetate esterase (ANAE), chloroacetate esterase (CAE) and acid phosphatase (AP).
Nucleic acid analysis. Genomic or cytoplasmic DNA was extracted as described (Hirt, 1967; Sambrook et al., 1989) . For Southern blotting, 30 ~tg of digested or undigested DNA was subjected to electrophoresis overnight at 40 V in 0-8% agarose, and blotted to a nylon membrane (Hybond-N ; Amersham). The filters were analysed by hybridization to BH10 probe (kindly provided by Dr R. C. Gallo, Bethesda, Md., U.S.A.), nick-translated with [32p]dCTP (NEN DuPont) as described previously (Federico et al., 1989) . For T cell receptor (TCR) analysis, 32p-labelled probes corresponding to the TCR/3 and 6 chains were used. To analyse immunoglobulin gene rearrangement a J# heavy chain probe was labelled. Viral DNA was also prepared by differential nuclear-cytoplasmic extraction. Cells or PBLs (107) were lysed in 20 mM-HEPES, 15 mM-KCI, 1.5 mM-magnesium acetate [Mg(OAc)2], I mM-DTT, 1 mM-PMSF and 0.5~ NP40. The cell lysate was centrifuged at 10000 r.p.m, for 10 min and supernatant, designated the cytoplasmic fraction, was extracted with phenol-chloroform and precipitated with ethanol. The pellet from this spin, resuspended in lysis buffer containing 80 mM-HEPES pH 7-5, 1.5 mM-DTT, 1.5 mMMg(OAc)2,100 mM-KCI, 1 mM-PMSF, 0.5% Triton X-100 and 0.88 Msucrose, was centrifuged at 4000 r.p.m, for 10 min. The pellet, designated as the nuclear fraction, was dissolved in 50 ktl of triple distilled sterile water.
Polymerase chain reaction (PCR)
. DNA extracted by standard methods was analysed by PCR using primers based on sequences of the HIV-1 genome, clone BH 10, amplifying gag (nucleotides 782 to 1092), env (nucleotides 7855 to 7989). PCR analysis was also carried out on materials from cellular lysates. Cells (106), washed twice in PBS, were lysed in 200 ~tl of a solution containing proteinase K (600 ~tg/ml), 10 mM-Tris, 1 mM-EDTA, 0-001% Triton X-100, 0-0001% SDS for 60 min at 65 °C, and for an additional 15 rain at 94 °C. The reaction mixture of 25 ~tl contained 1 ktg of DNA in 10 mM-Tris-HC1 pH 8.3, 50 mM-KCI, 1-5 mM-MgC12, 200 !aM each of the four dNTPs, 0.01% gelatin and 1 unit of Taq DNA polymerase (Perkin-Elmer Cetus). The samples were subjected to 35 amplification cycles in a programmable cycle instrument (Perkin-Elmer Cetus) set to denature the DNA for 2 min at 95 °C and to anneal the primers for 2 rain at 55 °C. The extension step in the final cycle was performed for 3 min at 72 °C. The amplified products from PCR were resolved in 1.8~ agarose gel, transferred to a nylon membrane and hybridized at 42 °C with a specific 32p-labelled oligonucleotide. Filters were then washed for 1 h at 42 °C in 2 × SSPE solution containing 0.18 M-NaCI, 0-01 ~t-sodium phosphate, 0-001 M-EDTA, 0.1 ~ SDS, pH 7-4. The dried membrane was exposed for 24 to 48 h in a Kodak cassette. For some experiments, as a control primers amplifying specific regions of the human fl-globin gene were used as described previously (Saiki et al., 1985 (Saiki et al., , 1988 .
Total RNA extracted from CEMss, HeLa, FT1 and FT4 cells in the log phase by the caesium chloride-guanidine isothiocyanate procedure (Chirgwin et al., 1979) was analysed by using primers from the sequence of the cDNA of human CD4 and fl-actin mRNA as described previously (Ponte et al., 1984; Maddon et al., 1985; Nakajima-Iijima et al., 1985) . For PCR analysis of cellular RNA, cDNA template was first generated by reverse transcription, cDNA synthesis was carried out in a volume of 25 ~tl containing 12 units of avian myeloblastosis virus reverse transcriptase (United States Biochemical Corporation), 1 ~tg of total cellular RNA, 10 mM-Tris-HC1 pH 8.3, 50 mM-KCI, 1.5 mMMgC12, 200 ~tM-NTP, 20 units RNase inhibitor, 150 ng of minus strand primer. The reaction was incubated at 65 °C for 5 min, 10 min in ice, and then for 60 min at 37 °C. All primers and probes used are shown in Table 1 .
HIV-I superinfection. Cells were harvested during the exponential growth phase, pretreated with 2 gg/ml polybrene (Sigma) for 60 min at 37 °C, washed with PBS (pH 7.2 to 7-4) and infected with HIV-1 strain H9/HTLV-III B (5.6 x l0 s TCIDso/ml as determined by syncytium induction on C8166 cells) at 37 °C for 3 h. The multiplicity of infection was 0.01 TCIDso/cell. Cells were then washed three times with PBS, resuspended in fresh RPMI supplemented with 20~ FCS at 2.5 x l0 s cells/ml and incubated at 37 °C in 5~ CO2. At designated times, cultures were sampled to determine cell number, viability, HIV-1 antigen production and the presence of reverse transcriptase (RT) activity in culture supernatants.
For blocking experiments, 106 cells were preincubated at 4 °C for 30 min with various concentrations of OKT4A and OKT26A MAbs (Ortho Diagnostic). Virus was then added at 37 °C and 3 h later cells were washed three times with PBS and resuspended in complete RPMI medium.
Assay for extracellular HIV release and viral antigen detection. Cellfree supernatant (1 ml) was pelleted at 100000 r.p.m, at 4 °C for 10 min (TL100; Beckman). The pellet was lysed in 70 tll 10 mn-Tris-HC1, 100 mM-NaC1, 1 mM-EDTA buffer containing 0.1 ~ Triton X-100, and 30 ~tl aliquots were assayed for RT as described previously (Rossi et al., 1988) . Supernatant fluids were also assayed for the presence of p24 antigen using a commercial kit based on an ELISA antigen capture test (HIVAG-1 ; Abbott Laboratories).
The presence of HIV-l-related p24 protein was also detected by a radioimmunoprecipitation assay (RIPA) with an anti-p24 MAb (British Biotechnology) or with human anti-HIV polyclonal serum. Cells were metabolically labelled with [3sS]cysteine (specific activity 1139.9 Ci/mmol) and [3sS]methionine (specific activity 1186 Ci/mmol; NEN DuPont). This assay was carried out as described elsewhere (Federico et al., 1989) .
Results

Origin and biological properties of FT cell lines
The cell lines described were derived from PBLs of a 35-year-old asymptomatic homosexual man seropositive for HIV-1 but seronegative for human T cell-lymphotropic virus type 1 (HTLV-1). In 1984 he was diagnosed as having HIV infection and lymphadenopathy (LAS), and virus was isolated from lymph nodes. In the following years enlarged lymph nodes disappeared, the serological pattern remained unchanged showing a complete humoral response against viral proteins, but F. Titti and others attempts to rescue virus from PBLs were always negative. In addition, in contrast to the survival curve of uninfected or HIV-l-infected lymphocytes, PBLs from this subject appeared to replicate in vitro. Thus, cloning of these PBLs was undertaken by the limiting dilution method in the presence of 10% IL-2 in fiat microtitre plates without a feeder layer. Single colonies (11 of 396 plated wells) were identified 10 to 15 days after cloning and transferred to a 24-well plate. Of the 11 clones, two (FT1 and FT4) survived and were further expanded, producing two established cell lines. The properties of these two lines (established in vitro by cell cloning, but not recloned for this study), continously grown in culture for more than 1 year, are summarized in Table 2 . Their growth features are similar; both clones reach a saturation density of 1-0 x l06 to 1.2 x 106 cells/ml after 3 days of culture, and are negative for extracellular virus release, as well as for viral mRNA and cytoplasmic viral proteins as detected by RT, PCR, antigen capture and RIPA (data not shown).
Exogenous IL-2 (added at the time of and immediately after cell cloning) was not necessary for the in vitro growth of PBLs. In fact, even after prolonged (48 h) starvation in IL-2-free medium, no changes in growth kinetics or [3H]thymidine incorporation in the presence of different concentrations of exogenous IL-2 were observed (data not shown). Since neither cell line requires the addition of growth factors to the medium and both exhibit autonomous growth in vitro, they were tested for possible paracrine release of cytokines able to support their growth. Both lines were negative for IL-2, IL-4 and IL-6 production and produced low levels of TNF-ct, whereas they released substantial amounts of GM-CSF and IFN (Table 2) . Thus, neither cell line produces cytokines known to support the growth of T cells in vitro.
Two months after the limiting dilution cloning, cells were recloned in agar with or without IL-2 to determine whether their unlimited growth potential would be accompanied by an immortalized state and a potentially malignant phenotype. Both cell lines were able to form colonies in agar. However, they did not induce solid tumours when injected subcutaneously (20 x 106 cells) into nude mice (Table 2) .
Phenotypic analysis
The phenotype of the FT1 and FT4 cell lines (Table 3) was studied using a large panel of MAbs. Both were positive for major histocompatibility complex (MHC) antigens (HLA-A, -B, -C, HLA-DP, -DQ and -DR) and negative for mature and immature T cell markers (CD2, CD3, CD4, CD5, CD7 and CD8), as well as for B (CD10, CD19, CD20 and CD22) and myelomonocytic (CD14, CD15 and CDllc) cell markers. The absence of CD4 gene expression was confirmed by immunostaining, Northern blotting and PCR analysis (data not shown). Furthermore, they do not express membrane markers typical of natural killer (NK) cells (CDllb, CDllc, CD56 and CD57), whereas both were positive for CD1 la and CD18 cell membrane adhesion molecules. In agreement with these findings, no cytotoxic or NK celllike activity, using K562 (NK +, LAK+), U937 (NK +, LAK +) and Daudi (NK-, LAK +) cells, was detected in vitro (data not shown). Both FT1 and FT4 cells were negative for the a-chain of the IL-2 receptor, but positive for the fl-chain (75K chain TAC antigen) (as detected by anti-TAC and anti-TU207 MAbs, respectively). These properties remained stable during approximately 12 months of culture. Thus, cell surface antigen characterization failed to identify clearly the nature of FT cells as they were negative for T, B, NK and monocyte-macrophage cell surface markers. Since highly undifferentiated T cells may be distinguished readily by Southern blot hybridization using TCR gene and Ig gene DNA probes, we used these markers to determine the lineage of FT cells. Fig. 1 . When DNA was digested with EcoRI and analysed by Southern blotting with a TCR probe, both cell types exhibited a TCR fl-gene rearrangement when compared to uncloned T and B cell lines. Using a TCR fl-chain constant region probe, we were able to detect rearrangement of this gene in FT cell DNA digested with EcoRI. Moreover, the absence of any TCR-6 band, indicating a complete rearrangement of the TCR a-gene, demonstrated a T cell origin for both the FT1 and FT4 cell lines. This was confirmed by the germline configuration of the DNA probed with an Ig gene probe. In fact, when DNA was digested with EcoRI and analysed by Southern blotting with a 5.6 kb BamHI-HindIII J# probe, FTI and FT4 cells showed the germline configuration of the Ig gene when compared to an Epstein-Barr virus (EBV)-transformed B cell line, thus ruling out the possibility of a B cell origin of FT cells. Finally, they were also negative for a/fl or ~/6 TCR membrane receptors, as well as for TCR mRNA expression as detected by Northern blot analysis (data not shown). 
Configuration analysis of the TCR fl-chain and of the immunoglobulin gene of FT1 and FT4 cells is shown in
Status of the E B V and HTLV-1 genomes
Since both FTI and FT4 cells show autonomous growth and the patient's sera were reactive for anti-EBV antibodies, the possibility that, despite their T cell nature, their immortalized status could be due to EBV transformation (Stevenson et al., 1986) was tested. High Mr DNA was analysed by Southern blotting using EBV 3-1 kb BamHI W (Polack et al., 1984) , 1.9 kb XhoI and 4-1 kb EcoRi I fragment probes (Raab-Traub & Flynn, 1986) representing, respectively, the large internal repeat sequence, the EcoRI D fragment unique sequence near the 3' end, and the terminal left repeat sequence. No specific signals were detected in either cell line (Fig. 2) . Negative results were also obtained from Southern blot analysis of DNA extracted from FT cells followed by hybridization with a genomic full-length HTLV-1 probe (data not shown).
Status of the HIV-1 genome
To assess whether FT1 and FT4 cells still contained the HIV genome, PCR analysis was performed on high Mr cellular DNA extracted from FT1 and FT4 cells, uninfected H9 cells and chronically infected cells of an established line (H9/HTLV-III~). In both FT1 and FT4 cells bands of the expected molecular size were detected by using primers amplifying specific regions of the HIV-1 genome: a 310 bp and a 134 bp product corresponding to the gag and env regions of HIV-1, respectively (Fig. 3) . However, when high Mr DNA digested with restriction endonucleases was analysed by Southern blotting, no signal was detected (data not shown). We then turned to differential nuclear-cytoplasmic extraction of DNA. The nuclear and cytoplasmic fractions were analysed by PCR using gag-and env-specific primers along with HIV-l-positive controls (Fig. 4) . Positive signals of the expected molecular size (310 bp and 134 bp) were detected only in the cytoplasmic fraction of FT 1 and FT4 cells, whereas only the nuclear fraction of chronically infected H9 cells was positive. Similarly, nuclear and cytoplasmic fractions of uncultured PBLs obtained from the original sample were analysed by PCR by using the same set of primers. Positive signals were detected only in the cytoplasm, as for FT1 and FT4 cells. To exclude the presence of nuclear contaminants in the cytoplasmic fraction, PCR was performed on the same samples by using primers amplifying a region (nucleotides 117 to 597) of the human fl-globin gene. As expected, the cytoplasmic fraction was negative and the nuclear fraction was positive. These results indicate that HIV-1 DNA is present only in extra-chromosomal forms and, most importantly, the in vitro genome status of the FT cell lines is representative of the in vivo situation, ruling out the possibility that selection had occurred during or after in vitro cell cloning. We next examined the structure of extrachromosomal viral DNA in FT cells by Hirt extraction (Fig. 5) . Southern blot analysis of uncut DNA revealed the presence of several bands: a 10.5 kb one corresponding to the linear dsDNA, and 7.1 and 6.9 kb bands representing a closed supercoiled circular form of unintegrated HIV-1 DNA probably containing several copies of the long terminal repeat (LTR). The band of 2.7 kb may represent incomplete viral sequences or products of degradation of viral DNA occurring during DNA purification. These bands are compatible with those already reported to exist in chronically infected cells, in biopsied lymph node tissue from a patient with AIDS (Shaw et al., 1984) and in HIV-l-infected PBLs in vitro (Kannagi et al., 1990) .
These viral DNA forms appear to persist through different in vitro passages. Hirt extracts of passages 22 and 80 were fractionated by gel electrophoresis in low melting point agarose. The DNA fraction between 7 and 12 kb was cut and analysed by PCR using primers amplifying the gag region (nucleotides 782 to 1092) (Fig.  6) . A specific 310 bp product was detected in both passages indicating that the extrachromosomal HIV-1 DNA forms appear to be stable in the FT1 and FT4 cell lines.
Susceptibility to HIV-1 superinfection
We evaluated whether the persistently infected FT cells were susceptible to HIV-1 superinfection. FT cells in log phase growth were superinfected with HIV-1 strain H9/HTLV-IIIB (m.o.i. 0.01 TCIDs0/cell). The superinfecting virus integrated into the host genome as indicated by PCR analysis of cellular lysates using primers amplifying the 5' LTR region (nucleotides 468 to 713) of HIV-1/HTLV-IIIB, but not the corresponding region of the HIV genome present in FT cells (Fig. 7) . Viral antigens were detected in cell lysates as well as in supernatants of superinfected FT cells (Table 4) . Furthermore, the presence of the viral p24 protein was * As determined at 3 days post-infection by antigen capture assay. t As determined by RIPA. For this experiment, supernatants (1 ml) of H9/HTLV-III B cells (515496 c.p.m./ml) and of H9 cell culture were used as controls. § ~D, Not done. II Twenty-three days after superinfection.
detected by R I P A using anti-p24 M A b s . N o syncytium f o r m a t i o n was observed following superinfection, but R T activity was repeatedly detected in the s u p e r n a t a n t of superinfected F T cells. T o confirm t h a t superinfecting H I V did replicate in F T cells with release of infectious progeny virus, cell-free s u p e r n a t a n t s o f F T cultures were used to infect C8166 cells (1 ml of cell-free s u p e r n a t a n t onto 5 x 105 C8166 cells). R e c o v e r y of HIV-1 was d e m o n s t r a t e d 3 days after infection by syncytium formation and detection of R T activity in the supern a t a n t of infected C8166 cells.
To d e t e r m i n e whether HIV-1 entry into C D 4 -F T cells might still be m e d i a t e d by C D 4 molecules expressed at very low levels (i.e. below the threshold of detection by flow cytometry and immunostaining), different concentrations (10 txg to 0.1 I.tg/106 cells) of a n t i -C D 4 M A b 
Discussion
Two permanently growing immature T cell lines have been established after in vitro cloning of PBLs from an asymptomatic HIV-1 seropositive, HTLV-1 seronegative homosexual subject at the time when his LAS was in remission. These cells grow independently of exogenous IL-2 and do not show any enhanced proliferative response when stimulated by different concentrations of IL-2. Both cell lines are able to form colonies when cloned in agar, but fail to grow as a solid tumour in nude mice. Therefore, they do not have a fully malignant phenotype.
FT cells are at a stage corresponding to the earliest stage of the T cell differentiation pathway as they possess a rearranged TCR (Fig. 1) , but do not express T cell membrane antigens (Table 2 ). Therefore they appear to resemble T-acute lymphoid leukaemia cells blocked at the earliest intrathymic T cell differentiation stage. It remains to be determined whether HIV infected an early T cell precursor or a more differentiated T cell that became undifferentiated as a consequence of HIV infection.
Populations of immature bone marrow myeloid progenitors as well as non-haematopoietic bone marrow stromal fibroblasts have been reported to be susceptible to HIV-1 infection in vivo (Folks et al., 1988; Scadden et al., 1990; Zucker-Franklin & Cao, 1989) .
One of the features of FT cells is their lack of spontaneous production of different types of cytokines, such as TNF-0t and IL-6, that are known to favour HIV replication. Instead they release significant levels of both GM-CSF and IFN-y. The latter finding is surprising in view of the fact that in the normal T cell lineage only activated mature T cells release IFN-y and GM-CSF (Kelso & Gough, 1987) .
Since FT cells do not harbour a detectable HTLV-1 genome (the only characterized human retrovirus able to transform T lymphocytes), it is not clear whether and how the presence of an extra-chromosomal form of HIV accounts for the immortalized state. The presence of EBV (a transforming DNA virus) sequences was also ruled out by Southern blotting. It is tempting to hypothesize that the transformation event possibly related to the activation of a latent cellular oncogene is somehow related to the presence of the HIV genome in FT cells, possibly via a trans-activation pathway mediated by the tat protein.
Our study shows that (i) T cell lines, derived from in vitro cloning of PBLs from an asymptomatic HIV-1 seropositive subject, harbour only extra-chromosomal viral DNA forms which remain stable throughout several in vitro passages and (ii) extra-chromosomal viral DNA forms, but not integrated provirus, are also present in uncultured PBLs from the same sample from which the two cell lines were derived.
The persistence of extrachromosomal HIV-1 DNA forms may be explained by the so-called nested selfintegration hypothesis (Pauza & Galindo, 1989) , according to which the extrachromosomal HIV-1 DNA genome replicates as DNA without an RNA intermediate, thus contributing to the production of defective viruses.
One possible explanation of the lack of integrated provirus in the FT genome is that FT cells originated from a cell population harbouring an integrated genome (LAS phase), but subsequently lost the provirus (Dahl et al., 1990) . Furthermore, in vitro evidence indicates that following infection of resting CD4 ÷ lymphocytes HIV-1 DNA is maintained extrachromosomally, although only for a limited time (Stevenson et al., 1990a) .
Several models have been proposed to explain the role of unintegrated HIV-1 in AIDS pathogenesis. In the model of resting CD4 ÷ lymphocytes as an HIV-1 reservoir in AIDS, events leading to the activation of resting T cells harbouring unintegrated viral DNA allow virus integration, active virus production and downregulation of CD4 expression. The unintegrated viral DNA could also serve as an efficient template for HIV-1 antigen production, although it appears that integration is required for productive infection (Stevenson et al., 1990a, b) .
The relevance of our results is strengthened by the observation that unintegrated HIV-1 DNA was detected in fresh uncultured PBLs of an asymptomatic seropositive subject and these PBLs exhibited autonomous growth capability in vitro. FT cells may represent a valuable tool for the study of the biological and molecular events which may occur in T cells harbouring unintegrated viral DNA. Attempts to clarify the role of such forms of viral DNA have been described, but only in systems based on the in vitro infection of uninfected or HIV-l-infected T cells (Pauza & Singh, 1990; Robinson & Zinkus, 1990) .
Although there were no detectable CD4 molecules on the cell surface and a marked down-regulation of CD4 mRNA was observed, FT1 and FT4 cells are susceptible to superinfection with HIV-1 at high multiplicity: extraceUular progeny virus is released which, in turn, reinfects CD4 ÷ cell lines, causing syncytium induction and RT production. If CD4 receptor sites were present on the FT cells at an undetectable level one would expect that the addition of OKT4A (which inhibits almost completely the infection of CEMss cells) should block superinfection of FT cells. Data indicated that treatment with OKT4A did not inhibit superinfection of FT1 and FT4 cells (Table 5 ). This suggests that HIV-1 superinfection is mediated by an interaction between HIV-1 and a cell surface receptor other than CD4, although we cannot rule out the possibility that other CD4 epitopes (e.g. the CDR3 region) may play a role in this superinfection. HIV-I infection of cell lines negative for CD4 membrane receptor or with a low level of CD4 expression has already been described (Cheng-Mayer et al., 1987; Li et al., 1990; Weber et al., 1989; Lusso et al., 1990; Kazazi et al., 1989; Sakaguchi et al., 1991) . What is peculiar about FT cells is that they are derived from cloned human PBLs, which like the FT cells also harbour extrachromosomal HIV-1 DNA, they show very low or no expression of the CD4 gene and they are susceptible to homologous superinfection.
Based on these observations, FT1 and FT4 cells may also represent a useful model to study putative cellular receptor(s) other than CD4 and the mechanism(s) involved in HIV-1 superinfection of persistently infected T cells.
